| Identification | Back Directory | [Name]
baohuoside II | [CAS]
55395-07-8 | [Synonyms]
baohuoside II
Icarisoside-A
IKarisoside A (Icarisoside-A
4H-1-Benzopyran-4-one,3-[(6-deoxy-a-L-mannopyranosyl)oxy]-5,7-dihydroxy-2-(4-hydroxyphenyl)-8-(3-methyl-2-buten-1-yl)-
4H-1-Benzopyran-4-one, 3-[(6-deoxy-α-L-mannopyranosyl)oxy]-5,7-dihydroxy-2-(4-hydroxyphenyl)-8-(3-methyl-2-buten-1-yl)-
3-[(6-Deoxy-alpha-L-mannopyranosyl)oxy]-5,7-dihydroxy-2-(4-hydroxyphenyl)-8-(3-methyl-2-buten-1-yl)-4H-1-benzopyran-4-one | [Molecular Formula]
C26H28O10 | [MDL Number]
MFCD26406176 | [MOL File]
55395-07-8.mol | [Molecular Weight]
500.49 |
| Hazard Information | Back Directory | [Uses]
IKarisoside A (Icarisoside-A) is a natural flavonol glycoside and has anti-inflammatory properties. | [References]
[1] Choi HJ, et al. Ikarisoside A inhibits inducible nitric oxide synthase in lipopolysaccharide-stimulated RAW 264.7 cells via p38 kinase and nuclear factor-kappaB signaling pathways. Eur J Pharmacol. 2008 Dec 28;601(1-3):171-8. DOI:10.1016/j.ejphar.2008.09.032
[2] Choi HJ, eta l. Inhibition of osteoclastogenic differentiation by Ikarisoside A in RAW 264.7 cells via JNK and NF-kappaB signaling pathways. Eur J Pharmacol. 2010 Jun 25;636(1-3):28-35. DOI:10.1016/j.ejphar.2010.03.023
[3] Li X, Toyohira Y, Horisita T, et al. Ikarisoside A inhibits acetylcholine-induced catecholamine secretion and synthesis by suppressing nicotinic acetylcholine receptor-ion channels in cultured bovine adrenal medullary cells. Naunyn Schmiedebergs Arch Pharmacol. 2015;388(12):1259-1269. DOI:10.1007/s00210-015-1161-y |
|
|